AG
NEO icon

Aperio Group’s NeoGenomics NEO Stock Holding History

Aperio Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2.85M Buy
52,878
+2,812
+6% +$127K 0.01% 1072
2020
Q3 		$1.85M Buy
50,066
+1,312
+3% +$48.8K 0.01% 1155
2020
Q2 		$1.51M Buy
48,754
+3,035
+7% +$84.1K 0.01% 1229
2020
Q1 		$1.26M Buy
45,719
+4,834
+12% +$145K 0.01% 1207
2019
Q4 		$1.2M Sell
40,885
-726
-2% -$17.3K ﹤0.01% 1344
2019
Q3 		$796K Sell
41,611
-2,814
-6% -$66K ﹤0.01% 1515
2019
Q2 		$975K Buy
44,425
+4,817
+12% +$106K ﹤0.01% 1415
2019
Q1 		$810K Buy
39,608
+5,644
+17% +$98.1K ﹤0.01% 1472
2018
Q4 		$428K Buy
33,964
+4,992
+17% +$74.4K ﹤0.01% 1772
2018
Q3 		$444K Buy
28,972
+2,063
+8% +$28.5K ﹤0.01% 1827
2018
Q2 		$353K Sell
26,909
-2,007
-7% -$22.1K ﹤0.01% 1928
2018
Q1 		$236K Buy
28,916
+1,532
+6% +$12.4K ﹤0.01% 2067
2017
Q4 		$243K Buy
+27,384
New +$253K ﹤0.01% 2059

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Aperio Group's NEO Position: Q4 2020 in Review

Aperio Group increased its NeoGenomics (NEO) stake by 5.6% in Q4 2020, buying an estimated $127K and bringing the position to 52,878 shares worth $2.85M. The position accounts for 0.01% of the portfolio, ranked #1072.

Aperio Group first reported a position in NEO in Q4 2017 and has held it in 13 quarters since. 340 funds tracked by Wall St. Rank hold NEO as of Q4 2020.

  • Aperio Group held 52,878 shares of NeoGenomics worth $2.85M as of Q4 2020.
  • Aperio Group bought 2,812 NeoGenomics shares in Q4 2020, an estimated $127K.
  • NeoGenomics made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1072 holding.
  • Aperio Group first reported a position in NeoGenomics in Q4 2017 and has held it in 13 quarters since.
  • 340 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.